Suchergebnisse - "Aguilar-Company, Juan"

PubPharm (45)

1

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Riveiro-Barciela, M. | Barreira-Díaz, A. | Salcedo, M. | +16

2

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer : Results of a propensity-matched analysis of the OnCovid registry

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mostaghim, A. | Minkove, S. | Aguilar-Company, J. | +43

3

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma : an analysis from the OnCovid registry

enthalten in: Therapeutic advances in medical oncology | 2024

von Vincenzi, B. | Cortellini, A. | Mazzocca, A. | +36

4

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Riveiro‐Barciela, M. | Barreira‐Díaz, A. | Salcedo, M. | +16

5

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Tagliamento, M. | Gennari, A. | Lambertini, M. | +50

6

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

7

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer : a joint analysis of OnCovid and ESMO-CoCARE registries

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Dettorre, G. | Dafni, U. | +40

8

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

enthalten in: British journal of cancer | 2022

von Cortellini, A. | Aguilar-Company, J. | Salazar, R. | +12

9

Long-term treatment with nebulized colistin in oncological patients with recurrent respiratory infections

enthalten in: Medicina clinica | 2022

von Suanzes, P. | Aguilar-Company, J. | Rodríguez-González, E. | +3

10

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Pinato, D. | Ferrante, D. | Aguilar-Company, J. | +149

1
2
3
4
5
Nächster »
[5]